71.[20221030]European Guideline for the Management of Kidney Transplan…
페이지 정보
작성자 신호식 작성일23-02-03 13:42 조회466회 댓글0건관련링크
-
https://youtu.be/kGL7SaBi2BE
436회 연결
https://youtu.be/kGL7SaBi2BE
본문
첨부한 자료(유튜브 클립, 참고문헌 등)를 학문적 목적으로만 사용해 주시길 부탁드립니다
Transpl Int
. 2022 Aug 10;35:10511. doi: 10.3389/ti.2022.10511. eCollection 2022.
European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
Nizam Mamode 1, Oriol Bestard 2, Frans Claas 3 4, Lucrezia Furian 5, Siân Griffin 6, Christophe Legendre 7, Liset Pengel 8, Maarten Naesens 9
Affiliations expand
PMID: 36033645 PMCID: PMC9399356 DOI: 10.3389/ti.2022.10511
Free PMC article
Abstract
This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies. Sensitization should be defined using a virtual parameter such as calculated Reaction Frequency (cRF), which assesses HLA antibodies derived from the actual organ donor population. Highly sensitized patients should be prioritized in kidney allocation schemes and linking allocation schemes may increase opportunities. The use of the ENGAGE 5 ((Bestard et al., Transpl Int, 2021, 34: 1005-1018) system and online calculators for assessing risk is recommended. The Eurotransplant Acceptable Mismatch program should be extended. If strategies for finding a compatible kidney are very unlikely to yield a transplant, desensitization may be considered and should be performed with plasma exchange or immunoadsorption, supplemented with IViG and/or anti-CD20 antibody. Newer therapies, such as imlifidase, may offer alternatives. Few studies compare HLA incompatible transplantation with remaining on the waiting list, and comparisons of morbidity or quality of life do not exist. Kidney paired exchange programs (KEP) should be more widely used and should include unspecified and deceased donors, as well as compatible living donor pairs. The use of a KEP is preferred to desensitization, but highly sensitized patients should not be left on a KEP list indefinitely if the option of a direct incompatible transplant exists.
Keywords: HLA antibodies; guidelines; incompatible; kidney transplantation; sensitization.
Transpl Int
. 2022 Aug 10;35:10511. doi: 10.3389/ti.2022.10511. eCollection 2022.
European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
Nizam Mamode 1, Oriol Bestard 2, Frans Claas 3 4, Lucrezia Furian 5, Siân Griffin 6, Christophe Legendre 7, Liset Pengel 8, Maarten Naesens 9
Affiliations expand
PMID: 36033645 PMCID: PMC9399356 DOI: 10.3389/ti.2022.10511
Free PMC article
Abstract
This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies. Sensitization should be defined using a virtual parameter such as calculated Reaction Frequency (cRF), which assesses HLA antibodies derived from the actual organ donor population. Highly sensitized patients should be prioritized in kidney allocation schemes and linking allocation schemes may increase opportunities. The use of the ENGAGE 5 ((Bestard et al., Transpl Int, 2021, 34: 1005-1018) system and online calculators for assessing risk is recommended. The Eurotransplant Acceptable Mismatch program should be extended. If strategies for finding a compatible kidney are very unlikely to yield a transplant, desensitization may be considered and should be performed with plasma exchange or immunoadsorption, supplemented with IViG and/or anti-CD20 antibody. Newer therapies, such as imlifidase, may offer alternatives. Few studies compare HLA incompatible transplantation with remaining on the waiting list, and comparisons of morbidity or quality of life do not exist. Kidney paired exchange programs (KEP) should be more widely used and should include unspecified and deceased donors, as well as compatible living donor pairs. The use of a KEP is preferred to desensitization, but highly sensitized patients should not be left on a KEP list indefinitely if the option of a direct incompatible transplant exists.
Keywords: HLA antibodies; guidelines; incompatible; kidney transplantation; sensitization.
